Pillstats
Rx only · Tablet, Film Coated · Oral

Mirtazapine

Brands: Remeron · Mirtazapine

30 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US101 NDCs
30 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN06AX11
RxCUI (US)15996
US makers31 labelers
Packages252
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 65 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.105$0.210$0.315$0.420Dec 2025Apr 2026Jul 2026
$0.329
Latest avg · Jul 22, 2026
+137%
Since Dec 17, 2025
30
Active US suppliers
25%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

374K747K1.1M1.5M2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2M
Rx · 2026 Q1
40.3M
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it30 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager36SUPPLYING
Aurobindo Pharma Limitedunknown27SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown26SUPPLYING
Aurolife Pharma, LLCunknown25SUPPLYING
Proficient Rx LPunknown13SUPPLYING
Apotex Corp.unknown12SUPPLYING
Preferred Pharmaceuticals Inc.unknown11SUPPLYING
REMEDYREPACK INC.repackager11SUPPLYING
A-S Medication Solutionsunknown10SUPPLYING
Camber Pharmaceuticals, Inc.unknown9SUPPLYING
Mylan Pharmaceuticals Inc.unknown9SUPPLYING
Prasco Laboratoriesunknown8SUPPLYING
Rising Pharma Holdings, Inc.unknown8SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown6SUPPLYING
Golden State Medical Supply, Inc.unknown6SUPPLYING

+ 16 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 18, 2020
    RECALLRecall (Class II): Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, …

    CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed — Recalling firm: Aurobindo Pharma USA Inc. — Nationwide within the United States

  • Nov 20, 2019
    RECALLRecall (Class I): Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08…

    Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets. — Recalling firm: AuroMedics Pharma LLC — Nationwide

  • Nov 20, 2019
    RECALLRecall (Class I): Mirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 088…

    Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets. — Recalling firm: AuroMedics Pharma LLC — Nationwide

  • Jan 27, 2017
    RECALLRecall (Class II): Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgant…

    Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled — Recalling firm: Mylan Institutional, Inc. (d.b.a. UDL Laboratories) — Nationwide

  • Jan 19, 2017
    RECALLRecall (Class II): Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuticals Inc.…

    Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle — Recalling firm: Mylan Pharmaceuticals Inc. — Nationwide